Endogenous production of C–C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis. (1st January 2020)

• Record Type: Journal Article
• Authors: Guo, Shan-Shan; Liu, Rui; Wen, Yue-Feng; Liu, Li-Ting; Yuan, Li; Li, Yan-Xian; Li, Yang; Hao, Wen-Wen; Peng, Jing-Yun; Chen, Dan-Ni; Tang, Qing-Nan; Sun, Xue-Song; Guo, Ling; Mo, Hao-Yuan; Qian, Chao-Nan; Zeng, Mu-Sheng; Bei, Jin-Xin; Sun, Shu-Yang; Chen, Qiu-Yan; Tang, Lin-Quan; Mai, Hai-Qiang
• Is Part Of: Cancer letters. Volume 468(2020)
• Page Start: 27
• Page End: 40
• Publication Date: 2020-01-01
• Subjects: C–C motif chemokine ligand 2 -- Nasopharyngeal carcinoma -- Radioresistance -- Metastasis -- Epithelial-mesenchymal transition; Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.canlet.2019.10.008
• Languages: English
• ISSNs: 0304-3835

Abstract

Abstract: Patients with recurrent nasopharyngeal carcinoma (NPC) have more co-existing distant metastasis than those of no-recurrence and are more likely to suffer distant metastasis after re-irradiation than patients with newly diagnosed NPC. However, the relationship between radioresistance and distant metastasis and the mechanisms involved in radioresistance-associated metastasis are still unclear. In this study, we proved that C–C motif chemokine ligand 2 (CCL2) expression was significantly elevated in HONE1-IR cells and recurrent NPC tumour. Inhibition of CCL2 enhanced sensitivity to radiotherapy in NPC cells. Moreover, autocrine CCL2 promoted NPC cell adaptive radioresistance, metastasis and epithelial-mesenchymal transition. Additionally, p53 activated CCL2 transcription. High CCL2 expression was highly associated with poorer locoregional recurrence free survival, progression free survival and overall survival in patients with newly diagnosed NPC. Notably, high CCL2 expression was an independent prognostic factor for distant metastasis free survival in recurrent NPC patients. Our results provide insights into the autocrine signalling mechanisms of CCL2 and suggest that inhibition of autocrine CCL2 may be a candidate treatment strategy for management of radioresistant NPC. Highlights: CCL2 expression was significantly elevated in radioresistant HONE1-IR cells and recurrent nasopharyngeal carcinoma (NPC). Autocrine CCL2 promoted adaptive radioresistance, metastasis and epithelial-mesenchymal transition of NPC cells. p53 activated CCL2 transcription. High CCL2 expression was highly associated with poorer clinical outcomes in NPC patients.